{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "26202245",
  "DateCompleted": {
    "Year": "2015",
    "Month": "12",
    "Day": "04"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "11",
    "Day": "13"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2015",
        "Month": "07",
        "Day": "22"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1128/JVI.00577-15"
    ],
    "Journal": {
      "ISSN": "1098-5514",
      "JournalIssue": {
        "Volume": "89",
        "Issue": "19",
        "PubDate": {
          "Year": "2015",
          "Month": "Oct"
        }
      },
      "Title": "Journal of virology",
      "ISOAbbreviation": "J Virol"
    },
    "ArticleTitle": "Apolipoprotein E, but Not Apolipoprotein B, Is Essential for Efficient Cell-to-Cell Transmission of Hepatitis C Virus.",
    "Pagination": {
      "StartPage": "9962",
      "EndPage": "9973",
      "MedlinePgn": "9962-73"
    },
    "Abstract": {
      "AbstractText": [
        "Hepatitis C virus (HCV) infects hepatocytes through two different routes: (i) cell-free particle diffusion followed by engagement with specific cellular receptors and (ii) cell-to-cell direct transmission mediated by mechanisms not well defined yet. HCV exits host cells in association with very-low-density lipoprotein (VLDL) components. VLDL particles contain apolipoproteins B (ApoB) and E (ApoE), which are required for viral assembly and/or infectivity. Based on these precedents, we decided to study whether these VLDL components participate in HCV cell-to-cell transmission in vitro. We observed that cell-to-cell viral spread was compromised after ApoE interference in donor but not in acceptor cells. In contrast, ApoB knockdown in either donor or acceptor cells did not impair cell-to-cell viral transmission. Interestingly, ApoB participated in the assembly of cell-free infective virions, suggesting a differential regulation of cell-to-cell and cell-free HCV infection. This study identifies host-specific factors involved in these distinct routes of infection that may unveil new therapeutic targets and advance our understanding of HCV pathogenesis.",
        "This work demonstrates that cell-to-cell transmission of HCV depends on ApoE but not ApoB. The data also indicate that ApoB is required for the assembly of cell-free infective particles, strongly suggesting the existence of mechanisms involving VLDL components that differentially regulate cell-free and cell-to-cell HCV transmission. These data clarify some of the questions regarding the role of VLDL in HCV pathogenesis and the transmission of the virus cell to cell as a possible mechanism of immune evasion and open the door to therapeutic intervention."
      ],
      "CopyrightInformation": "Copyright \u00a9 2015, American Society for Microbiology. All Rights Reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Molecular Biology Unit, Hospital Universitario de La Princesa, Instituto de Investigaci\u00f3n Sanitaria Princesa (IP), Madrid, Spain CIBERehd, Instituto de Salud Carlos III, Madrid, Spain."
          }
        ],
        "LastName": "Gondar",
        "ForeName": "Virg\u00ednia",
        "Initials": "V"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Molecular Biology Unit, Hospital Universitario de La Princesa, Instituto de Investigaci\u00f3n Sanitaria Princesa (IP), Madrid, Spain."
          }
        ],
        "LastName": "Molina-Jim\u00e9nez",
        "ForeName": "Francisca",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laboratory of Primate Model, Experimental Research Center for Infectious Diseases, Institute for Virus Research, Kyoto University, Kyoto, Japan."
          }
        ],
        "LastName": "Hishiki",
        "ForeName": "Takayuki",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CIBERehd, Instituto de Salud Carlos III, Madrid, Spain Liver Unit, Hospital Universitario de la Princesa (IP), Madrid, Spain."
          }
        ],
        "LastName": "Garc\u00eda-Buey",
        "ForeName": "Luisa",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CIBERehd, Instituto de Salud Carlos III, Madrid, Spain Liver Unit, Institut D'Investigacions Biom\u00e8dics August Pi i Sunyer (IDIBAPS), Hospital Cl\u00ednic, Barcelona, Spain."
          }
        ],
        "LastName": "Koutsoudakis",
        "ForeName": "George",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Ichikawa, Chiba, Japan."
          }
        ],
        "LastName": "Shimotohno",
        "ForeName": "Kunitada",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Molecular Biology Unit, Hospital Universitario de La Princesa, Instituto de Investigaci\u00f3n Sanitaria Princesa (IP), Madrid, Spain CIBERehd, Instituto de Salud Carlos III, Madrid, Spain igb2005@med.cornell.edu pedro.majano@salud.madrid.org."
          }
        ],
        "LastName": "Benedicto",
        "ForeName": "Ignacio",
        "Initials": "I"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Molecular Biology Unit, Hospital Universitario de La Princesa, Instituto de Investigaci\u00f3n Sanitaria Princesa (IP), Madrid, Spain CIBERehd, Instituto de Salud Carlos III, Madrid, Spain igb2005@med.cornell.edu pedro.majano@salud.madrid.org."
          }
        ],
        "LastName": "Majano",
        "ForeName": "Pedro L",
        "Initials": "PL"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Virol",
    "NlmUniqueID": "0113724",
    "ISSNLinking": "0022-538X"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Apolipoproteins B"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Apolipoproteins E"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Lipoproteins, VLDL"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "antagonists & inhibitors",
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "Apolipoproteins B"
    },
    {
      "QualifierName": [
        "antagonists & inhibitors",
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "Apolipoproteins E"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cell Line"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cell-Free System"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Gene Knockdown Techniques"
    },
    {
      "QualifierName": [
        "genetics",
        "pathogenicity",
        "physiology"
      ],
      "DescriptorName": "Hepacivirus"
    },
    {
      "QualifierName": [
        "metabolism",
        "transmission",
        "virology"
      ],
      "DescriptorName": "Hepatitis C"
    },
    {
      "QualifierName": [
        "metabolism",
        "virology"
      ],
      "DescriptorName": "Hepatocytes"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Host-Pathogen Interactions"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Lipoproteins, VLDL"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Models, Biological"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Virus Assembly"
    }
  ]
}